Roundup Cancer Claims After the Supreme Court’s FIFRA Ruling: Attorney911 Litigates the Design-Defect Pathway Still Open for St. Louis, Missouri Residents Like John Durnell, Who Developed Non-Hodgkin’s Lymphoma After 20+ Years Spraying Glyphosate as His Neighborhood’s Groundskeeper, We Pursue Bayer AG and Monsanto on the Theory That a Formulation IARC Classified Probably Carcinogenic Was Unreasonably Dangerous — and Bayer’s Removal of Glyphosate From Residential Roundup Supports That Claim, We Preserve the Exposure Logs, Purchase Receipts and Oncology Charts Before Memories Fade and Product Samples Disappear, Lupe Peña the Former Insurance-Defense Insider Who Knows How Bayer’s $16 Billion Claims Reserve Gets Valued and Denied, Missouri’s Pure Comparative-Fault Rule With No Non-Economic Cap in Product Liability, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Avvo-Rated Excellent, the Firm Has Recovered $50M+ for Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911
The Supreme Court Just Changed the Rules for Roundup Cancer Claims — But It Did Not Close the Courthouse Door If you used Roundup and later developed non-Hodgkin’s lymphoma, you are reading this at a moment the ground just shifted under your feet. On June 25, 2026, the United States Supreme Court ruled 7-2 that federal law blocks state-court lawsuits claiming the maker of Roundup failed to warn about cancer risks. Thousands of pending cases — roughly 200,000 claims filed nationwide against Bayer AG and its subsidiary Monsanto — just lost their primary legal theory. If you are one of those people, or someone who was about to file, you need to know exactly what the ruling does, what it does not do, and what legal paths remain open. We are going to tell you all of it — straight, without sugarcoating, and with the specificity your decision demands. The ruling blocks one theory: failure to warn. It does not block every theory. The Supreme Court’s own opinion left the door open to design defect claims — the argument that Roundup’s formulation containing glyphosate was unreasonably dangerous as designed, regardless of what the label said. A $7.25 billion class-action settlement…